The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy
- Theranostics, Published 2024-1-20, 14 (3) | https://doi.org/10.7150/thno.90376